Triple Negative Breast Cancer and the African American Woman
Did you know that breast cancer isn’t just one disease, but rather a disease made up of several subtypes, one of which is triple negative breast cancer?
Triple negative breast cancers are estrogen receptor-negative (ER-), progesterone receptor-negative (PR-) and HER2/neu-negative (HER2-) and about 15 to 20 percent of breast cancers are categorized as such. It’s important to note these tumors tend to occur more often in younger women and African American women. And, many BRCA1 and BRCA2 breast cancers also happen to be triple negative.
These triple negative tumors are often aggressive and have a poorer prognosis compared to the estrogen receptor-positive cancers. Treatment plans usually include some combination of surgery, radiation therapy and chemotherapy.
Although the reasons why younger African American women get triple negative breast cancer are not clear right now, one study suggests lifestyle factors might play a role. And higher rates of triple negative tumors may explain, to some degree, the poor prognosis of breast cancers diagnosed in younger African American women.
To learn more about triple negative breast cancer in African American women, we invite you to register for our upcoming webinar on Monday, Feb. 14 – Triple Negative Breast Cancer in the African American Woman – from 3-4 p.m. CST / 4-5 p.m. EST. Our two speakers for the hour will be Dr. Olufunmilayo Olopade from the University of Chicago Medical Center and survivor and Komen advocate, Tina Lewis. Check out the Facebook event here.Register for the webinar now!
Learn more about Triple Negative Breast Cancer here.
About the author
Nancy G. Brinker promised her dying sister, Susan G. Komen, she would do everything in her power to end breast cancer forever. In 1982, that promise became Susan G. Komen and launched the global breast cancer movement. Today, Komen is the world’s largest grassroots network of breast cancer survivors and activists fighting to save lives, empower people, ensure quality care for all and energize science to find the cures. Thanks to events like the Komen Race for the Cure®, we have invested more than $1.9 billion to fulfill our promise, becoming the largest source of nonprofit funds dedicated to the fight against breast cancer in the world.